Conversely, genetic or pharmacological enhancement of GPX4 activity has been shown to delay the onset of paralysis, preserve motor neurons, and prolong survival in ALS models (SOD1G93A) [237]. The gene discussed is GPX4; the disease is amyotrophic lateral sclerosis.